论文部分内容阅读
心律平(Rytomnorm)在西欧已较广泛地应用为抗心律失常药物,国内广州自1979年起已开始生产,对成人心律失常的疗效国内已有报告。1984年3月起,我们用以治疗小儿顽固性频发早搏20例。已随访一年以上,初步认为疗效满意,副作用少,服用方便,值得推广应用。对象与方法共20例。男5,女15。年龄3～12岁;平均7.5岁。临床病因:病毒性心肌炎11例,心肌病1例,原因不明8例。频发早搏分类:室性13例,房性3例,交界性4例。早搏频发程度按用药前连续5分钟心电图监测早搏
Rytomnorm has been widely used as an anti-arrhythmic drug in Western Europe. Guangzhou, China has started production since 1979, and the effect of arrhythmia in adults has been reported in China. From March 1984 onwards, we used to treat refractory infantile premature beats in 20 cases. Have been followed for more than one year, initially that the efficacy is satisfactory, less side effects, taking convenient, it is worth promoting. Subjects and methods a total of 20 cases. Male 5, female 15. Age 3 to 12 years old; average 7.5 years old. Clinical etiology: viral myocarditis in 11 cases, 1 case of cardiomyopathy, unexplained 8 cases. Frequent premature beats classification: 13 cases of ventricular, atrial in 3 cases, 4 cases of borderline. Frequency of premature beats by the drug for 5 minutes before ECG monitoring of premature beats